Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director | May 18, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date May 18, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 2,052 |
Reported balance
After 2026-05-18 transaction · row 1
1 source rowRow 1 · 2026-05-18 · Grant · Acquired 386 · Balance 2,052 F1: Award of stock |
Filing footnotes · ownership attribution and instrument terms
F1: Award of stock
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 19, 2026 13:17 UTC | CHEMED CORP CHE · Entity 3723 | GrantCapital Stock | 386 | $440.77 | $170,137.22 |
DisclosureSEC source: 0001193125-26-229800 · ownership.xml · nonDerivative · entry 1 DeLyons Ron · CIK 0001811257 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,052 F1 · acquired: Award of stock Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:01 UTC | CHEMED CORP CHE · Entity 3723 | GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-074989 · ownership.xml · nonDerivative · entry 1 DeLyons Ron · CIK 0001811257 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,666 F1 · acquired: Award of stock Read SEC document |
| May 20, 2024 Filed May 21, 2024 15:21 UTC | CHEMED CORP CHE · Entity 3723 | GrantCapital Stock | 284 | $564.34 | $160,272.56 |
DisclosureSEC source: 0000950170-24-062694 · ownership.xml · nonDerivative · entry 1 DeLyons Ron · CIK 0001811257 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389 F1 · kind: Award of stock Read SEC document |
| May 15, 2023 Filed May 16, 2023 17:07 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 294 | $545.69 | $160,432.86 |
DisclosureSEC source: 0001209191-23-029717 · doc4.xml · nonDerivative · entry 1 DeLyons Ron · CIK 0001811257 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,105 F1 · kind: Award of stock Read SEC document |
| May 16, 2022 Filed May 17, 2022 18:13 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 262 | $496.25 | $130,017.50 |
DisclosureSEC source: 0001209191-22-029529 · doc4.xml · nonDerivative · entry 1 DeLyons Ron · CIK 0001811257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 811 F1 · kind: Award of stock Read SEC document |
| May 17, 2021 Filed May 18, 2021 15:16 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 270 | $482.66 | $130,318.20 |
DisclosureSEC source: 0001209191-21-033386 · doc4.xml · nonDerivative · entry 1 DeLyons Ron · CIK 0001811257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549 F1 · kind: Award of stock Read SEC document |
| May 18, 2020 Filed May 19, 2020 18:06 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 279 | $466.43 | $130,133.97 |
DisclosureSEC source: 0001209191-20-030374 · doc4.xml · nonDerivative · entry 1 DeLyons Ron · CIK 0001811257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279 F1 · kind: Award of stock Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.